Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

A functional variant at miRNA-122 binding site in IL-1a 3' UTR predicts risk of recurrence in patients with oropharyngeal cancer.

Wang C, Sturgis EM, Chen X, Wei Q, Li G.

Oncotarget. 2016 Jun 7;7(23):34472-9. doi: 10.18632/oncotarget.8908.

2.

A functional variant at miRNA-122 binding site in IL-1α 3' UTR predicts risk and HPV-positive tumours of oropharyngeal cancer.

Zhang Y, Sturgis EM, Sun Y, Sun C, Wei Q, Huang Z, Li G.

Eur J Cancer. 2015 Jul;51(11):1415-23. doi: 10.1016/j.ejca.2015.04.016. Epub 2015 May 14.

3.

Genetic variants in microRNA-binding sites of DNA repair genes as predictors of recurrence in patients with squamous cell carcinoma of the oropharynx.

Zhu L, Sturgis EM, Zhang H, Lu Z, Tao Y, Wei Q, Li G.

Int J Cancer. 2017 Oct 1;141(7):1355-1364. doi: 10.1002/ijc.30849. Epub 2017 Jul 7.

4.

Genetic variants in TNF-α promoter are predictors of recurrence in patients with squamous cell carcinoma of oropharynx after definitive radiotherapy.

Zhang C, Sturgis EM, Zheng H, Song X, Wei P, Jin L, Chao L, Wei Q, Li G.

Int J Cancer. 2014 Apr 15;134(8):1907-15. doi: 10.1002/ijc.28512. Epub 2013 Oct 24.

5.

A functional variant at the miRNA binding site in E2F1 gene is associated with risk and tumor HPV16 status of oropharynx squamous cell carcinoma.

Yuan Y, Sturgis EM, Zhu L, Lu M, Li Y, Wei Q, Li G.

Mol Carcinog. 2017 Mar;56(3):1100-1106. doi: 10.1002/mc.22576. Epub 2016 Oct 20.

PMID:
27677255
6.

E2F transcription factor 2 variants as predictive biomarkers for recurrence risk in patients with squamous cell carcinoma of the oropharynx.

Li Y, Sturgis EM, Zhu L, Cao X, Wei Q, Zhang H, Li G.

Mol Carcinog. 2017 Apr;56(4):1335-1343. doi: 10.1002/mc.22595. Epub 2017 Jan 2.

7.

An insertion/deletion polymorphism at the microRNA-122 binding site in the interleukin-1α 3'-untranslated region is associated with a risk for osteoarthritis.

Yang F, Hu A, Zhao D, Guo L, Yang L, Wang B, Tian F, Liu B, Huang S, Xie H.

Mol Med Rep. 2015 Oct;12(4):6199-206. doi: 10.3892/mmr.2015.4121. Epub 2015 Jul 27.

PMID:
26239639
8.

Mouse double minute 4 variants modify susceptibility to risk of recurrence in patients with squamous cell carcinoma of the oropharynx.

Lu Z, Sturgis EM, Zhu L, Zhang H, Tao Y, Wei P, Wei Q, Li G.

Mol Carcinog. 2018 Mar;57(3):361-369. doi: 10.1002/mc.22760. Epub 2017 Nov 13.

9.

Variants in nucleotide excision repair core genes and susceptibility to recurrence of squamous cell carcinoma of the oropharynx.

Song X, Sturgis EM, Jin L, Wang Z, Wei Q, Li G.

Int J Cancer. 2013 Aug 1;133(3):695-704. doi: 10.1002/ijc.28051. Epub 2013 Feb 25.

10.

Significance of microRNA-related variants in susceptibility to recurrence of oropharyngeal cancer patients after definitive radiotherapy.

Chen X, Sturgis EM, Wang C, Cao X, Li Y, Wei Q, Li G.

Oncotarget. 2016 Jun 7;7(23):35015-25. doi: 10.18632/oncotarget.9014.

11.

An insertion/deletion polymorphism in the interleukin-1A 3'untranslated region confers risk for gastric cancer.

Zhang J, Shi H, Xue M, Yu Q, Yang L, Zheng S, Zhou C.

Cancer Biomark. 2016;16(3):359-65. doi: 10.3233/CBM-160574.

PMID:
26889982
12.

Interleukin-10 promoter variants predict HPV-positive tumors and survival of squamous cell carcinoma of the oropharynx.

Jin L, Sturgis EM, Cao X, Song X, Salahuddin T, Wei Q, Li G.

FASEB J. 2013 Jun;27(6):2496-503. doi: 10.1096/fj.12-226803. Epub 2013 Feb 21.

13.

Functional polymorphism rs3783553 in the 3'-untranslated region of IL-1A increased the risk of ischemic stroke: A case-control study.

Wang P, He Q, Liu C, He SZ, Zhu SY, Li YW, Su W, Xiang ST, Zhao B.

Medicine (Baltimore). 2017 Nov;96(46):e8522. doi: 10.1097/MD.0000000000008522.

14.

Apoptotic variants as predictors of risk of oropharyngeal cancer recurrence after definitive radiotherapy.

Zhang F, Sturgis EM, Sun Y, Zhang Y, Wei Q, Zhang C, Zheng H, Li G.

Int J Cancer. 2015 Nov 15;137(10):2454-61. doi: 10.1002/ijc.29604. Epub 2015 Jul 27.

15.

An insertion/deletion polymorphism at miRNA-122 binding site in the IL1A is associated with a reduced risk of cervical squamous cell carcinoma.

Huang J, Ni S, Li D, He Y.

Genet Test Mol Biomarkers. 2015 Jun;19(6):331-4. doi: 10.1089/gtmb.2015.0015. Epub 2015 May 8.

PMID:
25955681
16.

Potentially functional variants of p14ARF are associated with HPV-positive oropharyngeal cancer patients and survival after definitive chemoradiotherapy.

Song X, Sturgis EM, Huang Z, Li X, Li C, Wei Q, Li G.

Carcinogenesis. 2014 Jan;35(1):62-8. doi: 10.1093/carcin/bgt336. Epub 2013 Oct 8.

17.

4-bp insertion/deletion (rs3783553) polymorphism within the 3'UTR of IL1A contributes to the risk of prostate cancer in a sample of Iranian population.

Hashemi M, Bahari G, Sarhadi S, Eskandari E, Narouie B, Taheri M, Ghavami S.

J Cell Biochem. 2018 Mar;119(3):2627-2635. doi: 10.1002/jcb.26427. Epub 2017 Nov 21.

PMID:
29023981
18.
19.

Association of miRNA-122-binding site polymorphism at the interleukin-1 α gene and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.

Du Y, Han X, Pu R, Xie J, Zhang Y, Cao G.

Front Med. 2014 Jun;8(2):217-26. doi: 10.1007/s11684-014-0326-2. Epub 2014 Apr 21.

PMID:
24748463
20.

A let-7 microRNA polymorphism in the KRAS 3'-UTR is prognostic in oropharyngeal cancer.

De Ruyck K, Duprez F, Ferdinande L, Mbah C, Rios-Velazquez E, Hoebers F, Praet M, Deron P, Bonte K, Speel EJ, Libbrecht L, De Neve W, Lambin P, Thierens H.

Cancer Epidemiol. 2014 Oct;38(5):591-8. doi: 10.1016/j.canep.2014.07.008. Epub 2014 Aug 12.

PMID:
25127693

Supplemental Content

Support Center